RICHMOND, Va., April 15, 2025 /PRNewswire/ -- Markel Group Inc. (NYSE: MKL) will hold its annual "Omaha Brunch," an event at which the company's leaders take questions from investors, on Sunday, May 4 ...
Affimed N.V., a clinical-stage immuno-oncology company, announced that an abstract on its phase 2 LuminICE-203 study involving the innate cell engager acimtamig in combination with AlloNK has been ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results